Anatomic Pathology Market Forecast, Trends, Scope by 2031
The anatomic pathology market size is projected to reach US$ 53.27 billion by 2031 from US$ 30.22 billion in 2023. The market is expected to register a CAGR of 7.3% during 2023–2031. The integration of artificial intelligence and machine learning is likely to act as a future trend in the market.
Anatomic Pathology Market Analysis
Innovations in diagnostic techniques—including digital pathology, molecular diagnostics, and imaging technologies—enhance the accuracy and efficiency of pathology services, propelling the anatomic pathology market growth. An aging population is more susceptible to various diseases, leading to increased demand for pathology services for accurate diagnosis and treatment planning. In addition, increased awareness about health issues, robust screening programs contributing to early diagnosis, supportive regulatory frameworks, and favorable reimbursement policies are fueling the growth of the anatomic pathology market.
Anatomic Pathology Market Overview
India is expected to register the highest CAGR in the overall market. The National Cancer Registry Programme Report 2020 projected cancer cases in India to reach 14.61 million in 2022. The report also stated that the incidence of cancer is estimated to increase by 12.8% by 2025 compared to 2020. With the surging prevalence of cancer and advancements in healthcare infrastructure, government authorities in India are focusing on providing people with extended access to healthcare solutions. As per data by the Department for Promotion of Industry and Internal Trade (DPIIT), the inflow of foreign direct investments (FDIs) into the drugs and pharmaceuticals industry totaled US$ 17.74 billion from April 2000 to December 2020. Moreover, companies, organizations, governments, etc., make significant investments in diagnostic services and modern diagnostic facilities. Thus, such investments in the healthcare sector bolster the anatomic pathology market growth in India.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Anatomic Pathology Market: Strategic Insights
Market Size Value in US$ 22,800.20 Million in 2022 Market Size Value by US$ 33,145.78 Million by 2028 Growth rate CAGR of 6.4% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Anatomic Pathology Market: Strategic Insights
| Market Size Value in | US$ 22,800.20 Million in 2022 |
| Market Size Value by | US$ 33,145.78 Million by 2028 |
| Growth rate | CAGR of 6.4% from 2022 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Anatomic Pathology Market Drivers and Opportunities
Increase in Prevalence of Cancer and Kidney Diseases
Anatomic pathology is useful in identifying abnormalities that can help diagnose diseases, such as autoimmune diseases, kidney and liver diseases, and cancer. Histopathology, which involves studying tissue changes caused by diseases, is a vital part of anatomic pathology. Cancer has a major impact on society across the world. The burden of cancer on healthcare systems is significantly increasing worldwide as it is among the leading causes of death. The World Health Organization (WHO) ranks cancer as the second-leading cause of mortality worldwide. According to data published by the World Cancer Research Fund International, ~20 million new cases of cancer were registered in 2022 globally. Moreover, as per the data published by the World Health Organization (WHO), nearly 10 million deaths worldwide were caused by cancer in 2020. The National Center for Health Statistics data estimates that the diagnosis of new cancer cases in the US is likely to reach 2 million in 2024. In addition, ~0.61 million people are likely to die in 2024 in the US due to cancer. According to data published by Macmillan Cancer Support, ~392,000 people in the UK are diagnosed with cancer every year, while ~167,000 people die due to the disease each year.
The prevalence of chronic kidney disease is growing due to the increase in the geriatric population. According to the Centers for Disease Control and Prevention, in 2023, ~35.5 million people in the US suffered from chronic kidney diseases. Biopsy, an anatomic pathology technique, is used for the detection of cancer and chronic kidney disease. Owing to the increasing prevalence of cancer and kidney disease, government agencies, healthcare providers, and institutions are being compelled to contribute toward disease diagnosis and treatment initiatives. Thus, a surge in the prevalence of cancer and other targeted diseases, such as autoimmune diseases, and kidney and liver diseases is driving the global anatomic pathology market growth.
Growing Focus on Personalized Medicines to Offer Opportunity for Market
Personalized medicines are mainly designed by considering individuals' genetic profiles to guide the decisions made with respect to the prevention, diagnosis, and treatment of a disease. They provide an opportunity for drug manufacturers to develop agents that target patient groups that do not respond to medications as intended or for them who do not respond as expected to traditional healthcare practices. There is much evidence indicating that a substantial portion of the variability in drug response depends on factors that are genetically controlled, including age, nutrition, environmental exposure, and health status. Genomics plays an important role in the emergence of personalized medicines, as having the knowledge of a patient's genetic profile would help doctors in selecting an apt medication. Personalized medicines are helpful in improving healthcare by enabling each patient to receive earlier diagnoses, risk assessments, and optimal treatments.
Pathologists play an important role in developing and implementing molecular and genomic tests in practice. Personalized medicines are used in the treatment of diseases such as breast cancer and cardiovascular diseases. Personalized anticancer medicines exhibit fewer and less severe side effects than other types of treatment as they are designed for more specific action. Further, with the ongoing progress in research and clinical studies, personalized medicines are likely to reach even greater potential to improve the quality of patient care. Thus, the growing focus on personalized medicines is expected to boost the anatomic pathology market growth.
Anatomic Pathology Market Report Segmentation Analysis
Key segments that contributed to the derivation of the anatomic pathology market analysis are products and services, application, and end user.
- Based on products and services, the anatomic pathology market is segmented into instruments, consumables, and services. The services segment is further bifurcated into histopathology and cytopathology. The instruments segment is further divided into microtomes and cryostat, automatic stainers, tissue processors, and others. The instruments segment held the largest market share in 2023.
- By application, the market is segmented into disease diagnosis, drug discovery and development, and others. The disease diagnosis segment held the largest market share in 2023.
- Based on end user, the anatomic pathology market is divided into hospitals, research laboratories, diagnostic laboratories, and others. The hospitals segment held the largest market share in 2023.
Anatomic Pathology Market Share Analysis by Geography
The geographic scope of the anatomic pathology market report is mainly divided into five regions: North America, Asia Pacific, Europe, the South & Central America, and the Middle East & Africa. North America dominated the market in 2023. The growth of the market in this region is attributed to the growing prevalence of cancer, increasing government initiatives for screening cancer patients, rising focus on efficient disease diagnosis, and surging need for advanced healthcare systems. Moreover, increased research and development efforts undertaken by the market players, coupled with product launches, are likely to drive the growth of the anatomic pathology market in North America during the forecast period. Players operating in the US anatomic pathology market continuously focus on the development of innovative and convenient instruments and consumables for pathological procedures. In November 2023, Illumina Inc., US, a global leader in DNA sequencing and array-based technologies, introduced TruSight Oncology 500 ctDNA v2 (plate number 1 ctDNA v2), a new version of its distributed liquid biopsy assay that allows comprehensive noninvasive genomic profiling of circulating tumor DNA from blood, complementing tissue-based testing. Asia Pacific is anticipated to register the highest CAGR during the forecast period.
Anatomic Pathology Market Report Scope
Anatomic Pathology Market News and Recent Developments
The anatomic pathology market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the market are listed below:
- Agilent Technologies Inc. partnered with Hamamatsu Photonics K.K., a leading provider of whole slide imaging systems. The collaboration involved incorporating Hamamatsu's NanoZoomer range, including the S360MD Slide scanner system, into Agilent's digital pathology solution. The addition of the NanoZoomer Slide scanner systems, which convert glass slides into high-resolution digital data through high-speed scanning, has completed Agilent's offering of an open and agnostic digital pathology workflow aimed at accelerating breakthroughs in precision medicine. (Source: Agilent Technologies Inc., Company Website, March 2023)
- Epredia, a subsidiary of PHC Corporation, and NovaScan, Inc., a company that develops breakthrough technology for cancer detection and stratification, announced signing a letter of intent for a U.S. exclusive commercial distribution agreement for MarginScan, a medical device that will support physicians in real-time detection of non-melanoma skin cancer. Epredia has engaged Avantik, a company specializing in supporting diagnostic labs with their operations, to get this new device into the hands of Mohs surgeons. (Source: PHC Corporation, Company Website, May 2024)
Anatomic Pathology Market Report Coverage and Deliverables
The "Anatomic Pathology Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
- Anatomic pathology market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Anatomic pathology market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PESTand SWOT analysis
- Anatomic pathology market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the anatomic pathology market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product and Service, Application, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, RoAPAC, RoSCAM, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The anatomic pathology market value is expected to reach US$ 53.27 billion by 2031.
The market is expected to register a CAGR of 7.3% during 2023–2031.
The services segment dominated the global anatomic pathology market and held the largest revenue share of 40.04% in 2021.
F. Hoffmann-La Roche Ltd, Beckman Coulter Inc, Hologic Inc, Agilent Technologies Inc, BioGenex Laboratories Inc, Diapath S.p.A., Bio SB, Merck KGaA, BD, and PHC Holdings Corporation are among the key players in the market.
The integration of artificial intelligence and machine learning is expected to be a prime trend in the market in the coming years.
North America dominated the market in 2023.
The increase in the prevalence of cancer and kidney diseases and the rise in the number of strategic initiatives are among the most significant factors fueling the market growth.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Anatomic Pathology Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Anatomic Pathology Market – Key Market Dynamics
5.1 Anatomic Pathology Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Increase in Prevalence of Cancer and Kidney Diseases
5.2.2 Rise in Number of Strategic Initiatives
5.3 Market Restraints
5.3.1 Lack of Skilled Professionals
5.3.2 Stringent Government Regulations
5.4 Market Opportunities
5.4.1 Growing Focus on Personalized Medicines
5.5 Future Trends
5.5.1 Integration of Artificial Intelligence and Machine Learning
5.6 Impact of Drivers and Restraints:
6. Anatomic Pathology Market – Global Market Analysis
6.1 Anatomic Pathology Market Revenue (US$ Million), 2021–2031
6.2 Anatomic Pathology Market Forecast Analysis
7. Anatomic Pathology Market Analysis – by Product and Services
7.1 Services
7.1.1 Overview
7.1.2 Services: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Instruments
7.2.1 Overview
7.2.2 Instruments: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Consumables
7.3.1 Overview
7.3.2 Consumables: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
8. Anatomic Pathology Market Analysis – by Application
8.1 Disease Diagnosis
8.1.1 Overview
8.1.2 Disease Diagnosis: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Drug Discovery and Development
8.2.1 Overview
8.2.2 Drug Discovery and Development: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Others
8.3.1 Overview
8.3.2 Others: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
9. Anatomic Pathology Market Analysis – by End User
9.1 Hospitals
9.1.1 Overview
9.1.2 Hospitals: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Research Laboratories
9.2.1 Overview
9.2.2 Research Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Diagnostic Laboratories
9.3.1 Overview
9.3.2 Diagnostic Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Others
9.4.1 Overview
9.4.2 Others: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10. Anatomic Pathology Market – Geographical Analysis
10.1 Overview
10.2 North America
10.2.1 North America Anatomic Pathology Market Overview
10.2.2 North America: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3 North America: Anatomic Pathology Market – Revenue and Forecast Analysis – by Product and Services
10.2.4 North America: Anatomic Pathology Market – Revenue and Forecast Analysis – by Services
10.2.5 North America: Anatomic Pathology Market – Revenue and Forecast Analysis – by Instruments
10.2.6 North America: Anatomic Pathology Market – Revenue and Forecast Analysis – by Application
10.2.7 North America: Anatomic Pathology Market – Revenue and Forecast Analysis – by End User
10.2.8 North America: Anatomic Pathology Market – Revenue and Forecast Analysis – by Country
10.2.8.1 United States: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.2.8.1.1 United States: Anatomic Pathology Market Breakdown, by Product and Services
10.2.8.1.1.1 United States: Anatomic Pathology Market Breakdown, by Services
10.2.8.1.1.2 United States: Anatomic Pathology Market Breakdown, by Instruments
10.2.8.1.2 United States: Anatomic Pathology Market Breakdown, by Application
10.2.8.1.3 United States: Anatomic Pathology Market Breakdown, by End User
10.2.8.2 Canada: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.2.8.2.1 Canada: Anatomic Pathology Market Breakdown, by Product and Services
10.2.8.2.1.1 Canada: Anatomic Pathology Market Breakdown, by Services
10.2.8.2.1.2 Canada: Anatomic Pathology Market Breakdown, by Instruments
10.2.8.2.2 Canada: Anatomic Pathology Market Breakdown, by Application
10.2.8.2.3 Canada: Anatomic Pathology Market Breakdown, by End User
10.2.8.3 Mexico: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.2.8.3.1 Mexico: Anatomic Pathology Market Breakdown, by Product and Services
10.2.8.3.1.1 Mexico: Anatomic Pathology Market Breakdown, by Services
10.2.8.3.1.2 Mexico: Anatomic Pathology Market Breakdown, by Instruments
10.2.8.3.2 Mexico: Anatomic Pathology Market Breakdown, by Application
10.2.8.3.3 Mexico: Anatomic Pathology Market Breakdown, by End User
10.3 Europe
10.3.1 Europe Anatomic Pathology Market Overview
10.3.2 Europe: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3 Europe: Anatomic Pathology Market – Revenue and Forecast Analysis – by Product and Services
10.3.4 Europe: Anatomic Pathology Market – Revenue and Forecast Analysis – by Services
10.3.5 Europe: Anatomic Pathology Market – Revenue and Forecast Analysis – by Instruments
10.3.6 Europe: Anatomic Pathology Market – Revenue and Forecast Analysis – by Application
10.3.7 Europe: Anatomic Pathology Market – Revenue and Forecast Analysis – by End User
10.3.8 Europe: Anatomic Pathology Market – Revenue and Forecast Analysis – by Country
10.3.8.1 United Kingdom: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.3.8.1.1 United Kingdom: Anatomic Pathology Market Breakdown, by Product and Services
10.3.8.1.1.1 United Kingdom: Anatomic Pathology Market Breakdown, by Services
10.3.8.1.1.2 United Kingdom: Anatomic Pathology Market Breakdown, by Instruments
10.3.8.1.2 United Kingdom: Anatomic Pathology Market Breakdown, by Application
10.3.8.1.3 United Kingdom: Anatomic Pathology Market Breakdown, by End User
10.3.8.2 Germany: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.3.8.2.1 Germany: Anatomic Pathology Market Breakdown, by Product and Services
10.3.8.2.1.1 Germany: Anatomic Pathology Market Breakdown, by Services
10.3.8.2.1.2 Germany: Anatomic Pathology Market Breakdown, by Instruments
10.3.8.2.2 Germany: Anatomic Pathology Market Breakdown, by Application
10.3.8.2.3 Germany: Anatomic Pathology Market Breakdown, by End User
10.3.8.3 France: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.3.8.3.1 France: Anatomic Pathology Market Breakdown, by Product and Services
10.3.8.3.1.1 France: Anatomic Pathology Market Breakdown, by Services
10.3.8.3.1.2 rance: Anatomic Pathology Market Breakdown, by Instruments
10.3.8.3.2 France: Anatomic Pathology Market Breakdown, by Application
10.3.8.3.3 France: Anatomic Pathology Market Breakdown, by End User
10.3.8.4 Italy: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.3.8.4.1 Italy: Anatomic Pathology Market Breakdown, by Product and Services
10.3.8.4.1.1 Italy: Anatomic Pathology Market Breakdown, by Services
10.3.8.4.1.2 Italy: Anatomic Pathology Market Breakdown, by Instruments
10.3.8.4.2 Italy: Anatomic Pathology Market Breakdown, by Application
10.3.8.4.3 Italy: Anatomic Pathology Market Breakdown, by End User
10.3.8.5 Spain: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.3.8.5.1 Spain: Anatomic Pathology Market Breakdown, by Product and Services
10.3.8.5.1.1 Spain: Anatomic Pathology Market Breakdown, by Services
10.3.8.5.1.2 Spain: Anatomic Pathology Market Breakdown, by Instruments
10.3.8.5.2 Spain: Anatomic Pathology Market Breakdown, by Application
10.3.8.5.3 Spain: Anatomic Pathology Market Breakdown, by End User
10.3.8.6 Rest of Europe: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.3.8.6.1 Rest of Europe: Anatomic Pathology Market Breakdown, by Product and Services
10.3.8.6.1.1 Rest of Europe: Anatomic Pathology Market Breakdown, by Services
10.3.8.6.1.2 Rest of Europe: Anatomic Pathology Market Breakdown, by Instruments
10.3.8.6.2 Rest of Europe: Anatomic Pathology Market Breakdown, by Application
10.3.8.6.3 Rest of Europe: Anatomic Pathology Market Breakdown, by End User
10.4 Asia Pacific
10.4.1 Asia Pacific Anatomic Pathology Market Overview
10.4.2 Asia Pacific: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.4.3 Asia Pacific: Anatomic Pathology Market – Revenue and Forecast Analysis – by Product and Services
10.4.4 Asia Pacific: Anatomic Pathology Market – Revenue and Forecast Analysis – by Services
10.4.5 Asia Pacific: Anatomic Pathology Market – Revenue and Forecast Analysis – by Instruments
10.4.6 Asia Pacific: Anatomic Pathology Market – Revenue and Forecast Analysis – by Application
10.4.7 Asia Pacific: Anatomic Pathology Market – Revenue and Forecast Analysis – by End User
10.4.8 Asia Pacific: Anatomic Pathology Market – Revenue and Forecast Analysis – by Country
10.4.8.1 China: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.4.8.1.1 China: Anatomic Pathology Market Breakdown, by Product and Services
10.4.8.1.1.1 China: Anatomic Pathology Market Breakdown, by Services
10.4.8.1.1.2 China: Anatomic Pathology Market Breakdown, by Instruments
10.4.8.1.2 China: Anatomic Pathology Market Breakdown, by Application
10.4.8.1.3 China: Anatomic Pathology Market Breakdown, by End User
10.4.8.2 Japan: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.4.8.2.1 Japan: Anatomic Pathology Market Breakdown, by Product and Services
10.4.8.2.1.1 Japan: Anatomic Pathology Market Breakdown, by Services
10.4.8.2.1.2 Japan: Anatomic Pathology Market Breakdown, by Instruments
10.4.8.2.2 Japan: Anatomic Pathology Market Breakdown, by Application
10.4.8.2.3 Japan: Anatomic Pathology Market Breakdown, by End User
10.4.8.3 India: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.4.8.3.1 India: Anatomic Pathology Market Breakdown, by Product and Services
10.4.8.3.1.1 India: Anatomic Pathology Market Breakdown, by Services
10.4.8.3.1.2 India: Anatomic Pathology Market Breakdown, by Instruments
10.4.8.3.2 India: Anatomic Pathology Market Breakdown, by Application
10.4.8.3.3 India: Anatomic Pathology Market Breakdown, by End User
10.4.8.4 Australia: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.4.8.4.1 Australia: Anatomic Pathology Market Breakdown, by Product and Services
10.4.8.4.1.1 Australia: Anatomic Pathology Market Breakdown, by Services
10.4.8.4.1.2 Australia: Anatomic Pathology Market Breakdown, by Instruments
10.4.8.4.2 Australia: Anatomic Pathology Market Breakdown, by Application
10.4.8.4.3 Australia: Anatomic Pathology Market Breakdown, by End User
10.4.8.5 South Korea: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.4.8.5.1 South Korea: Anatomic Pathology Market Breakdown, by Product and Services
10.4.8.5.1.1 South Korea: Anatomic Pathology Market Breakdown, by Services
10.4.8.5.1.2 South Korea: Anatomic Pathology Market Breakdown, by Instruments
10.4.8.5.2 South Korea: Anatomic Pathology Market Breakdown, by Application
10.4.8.5.3 South Korea: Anatomic Pathology Market Breakdown, by End User
10.4.8.6 Rest of APAC: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.4.8.6.1 Rest of APAC: Anatomic Pathology Market Breakdown, by Product and Services
10.4.8.6.1.1 Rest of APAC: Anatomic Pathology Market Breakdown, by Services
10.4.8.6.1.2 Rest of APAC: Anatomic Pathology Market Breakdown, by Instruments
10.4.8.6.2 Rest of APAC: Anatomic Pathology Market Breakdown, by Application
10.4.8.6.3 Rest of APAC: Anatomic Pathology Market Breakdown, by End User
10.5 Middle East and Africa
10.5.1 Middle East and Africa Anatomic Pathology Market Overview
10.5.2 Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.5.3 Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast Analysis – by Product and Services
10.5.4 Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast Analysis – by Services
10.5.5 Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast Analysis – by Instruments
10.5.6 Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast Analysis – by Application
10.5.7 Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast Analysis – by End User
10.5.8 Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast Analysis – by Country
10.5.8.1 South Africa: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.5.8.1.1 South Africa: Anatomic Pathology Market Breakdown, by Product and Services
10.5.8.1.1.1 South Africa: Anatomic Pathology Market Breakdown, by Services
10.5.8.1.1.2 South Africa: Anatomic Pathology Market Breakdown, by Instruments
10.5.8.1.2 South Africa: Anatomic Pathology Market Breakdown, by Application
10.5.8.1.3 South Africa: Anatomic Pathology Market Breakdown, by End User
10.5.8.2 Saudi Arabia: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.5.8.2.1 Saudi Arabia: Anatomic Pathology Market Breakdown, by Product and Services
10.5.8.2.1.1 Saudi Arabia: Anatomic Pathology Market Breakdown, by Services
10.5.8.2.1.2 Saudi Arabia: Anatomic Pathology Market Breakdown, by Instruments
10.5.8.2.2 Saudi Arabia: Anatomic Pathology Market Breakdown, by Application
10.5.8.2.3 Saudi Arabia: Anatomic Pathology Market Breakdown, by End User
10.5.8.3 United Arab Emirates: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.5.8.3.1 United Arab Emirates: Anatomic Pathology Market Breakdown, by Product and Services
10.5.8.3.1.1 United Arab Emirates: Anatomic Pathology Market Breakdown, by Services
10.5.8.3.1.2 United Arab Emirates: Anatomic Pathology Market Breakdown, by Instruments
10.5.8.3.2 United Arab Emirates: Anatomic Pathology Market Breakdown, by Application
10.5.8.3.3 United Arab Emirates: Anatomic Pathology Market Breakdown, by End User
10.5.8.4 Rest of Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.5.8.4.1 Rest of Middle East and Africa: Anatomic Pathology Market Breakdown, by Product and Services
10.5.8.4.1.1 Rest of Middle East and Africa: Anatomic Pathology Market Breakdown, by Services
10.5.8.4.1.2 Rest of Middle East and Africa: Anatomic Pathology Market Breakdown, by Instruments
10.5.8.4.2 Rest of Middle East and Africa: Anatomic Pathology Market Breakdown, by Application
10.5.8.4.3 Rest of Middle East and Africa: Anatomic Pathology Market Breakdown, by End User
10.6 South and Central America
10.6.1 South and Central America Anatomic Pathology Market Overview
10.6.2 South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.6.3 South and Central America: Anatomic Pathology Market – Revenue and Forecast Analysis – by Product and Services
10.6.4 South and Central America: Anatomic Pathology Market – Revenue and Forecast Analysis – by Services
10.6.5 South and Central America: Anatomic Pathology Market – Revenue and Forecast Analysis – by Instruments
10.6.6 South and Central America: Anatomic Pathology Market – Revenue and Forecast Analysis – by Application
10.6.7 South and Central America: Anatomic Pathology Market – Revenue and Forecast Analysis – by End User
10.6.8 South and Central America: Anatomic Pathology Market – Revenue and Forecast Analysis – by Country
10.6.8.1 Brazil: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.6.8.1.1 Brazil: Anatomic Pathology Market Breakdown, by Product and Services
10.6.8.1.1.1 Brazil: Anatomic Pathology Market Breakdown, by Services
10.6.8.1.1.2 Brazil: Anatomic Pathology Market Breakdown, by Instruments
10.6.8.1.2 Brazil: Anatomic Pathology Market Breakdown, by Application
10.6.8.1.3 Brazil: Anatomic Pathology Market Breakdown, by End User
10.6.8.2 Argentina: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.6.8.2.1 Argentina: Anatomic Pathology Market Breakdown, by Product and Services
10.6.8.2.1.1 Argentina: Anatomic Pathology Market Breakdown, by Services
10.6.8.2.1.2 Argentina: Anatomic Pathology Market Breakdown, by Instruments
10.6.8.2.2 Argentina: Anatomic Pathology Market Breakdown, by Application
10.6.8.2.3 Argentina: Anatomic Pathology Market Breakdown, by End User
10.6.8.3 Rest of South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.6.8.3.1 Rest of South and Central America: Anatomic Pathology Market Breakdown, by Product and Services
10.6.8.3.1.1 Rest of South and Central America: Anatomic Pathology Market Breakdown, by Services
10.6.8.3.1.2 Rest of South and Central America: Anatomic Pathology Market Breakdown, by Instruments
10.6.8.3.2 Rest of South and Central America: Anatomic Pathology Market Breakdown, by Application
10.6.8.3.3 Rest of South and Central America: Anatomic Pathology Market Breakdown, by End User
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in Anatomic Pathology Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 F. Hoffmann-La Roche Ltd
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Beckman Coulter Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Hologic Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Agilent Technologies Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 BioGenex Laboratories Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Diapath S.p.A.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Bio SB
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Merck KGaA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 PHC Holdings Corporation
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
List of Tables
Table 1. Anatomic Pathology Market Segmentation
Table 2. Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
Table 3. Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million) – by Product and Services
Table 4. Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 5. Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 6. North America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 7. North America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 8. North America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 9. North America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 10. North America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 11. United States: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 12. United States: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 13. United States: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 14. United States: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 15. United States: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 16. Canada: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 17. Canada: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 18. Canada: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 19. Canada: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 20. Canada: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 21. Mexico: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 22. Mexico: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 23. Mexico: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 24. Mexico: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 25. Mexico: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 26. Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 27. Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 28. Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 29. Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 30. Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 31. United Kingdom: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 32. United Kingdom: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 33. United Kingdom: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 34. United Kingdom: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 35. United Kingdom: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 36. Germany: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 37. Germany: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 38. Germany: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 39. Germany: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 40. Germany: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 41. France: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 42. France: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 43. France: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 44. France: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 45. France: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 46. Italy: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 47. Italy: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 48. Italy: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 49. Italy: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 50. Italy: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 51. Spain: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 52. Spain: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 53. Spain: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 54. Spain: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 55. Spain: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 56. Rest of Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 57. Rest of Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 58. Rest of Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 59. Rest of Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 60. Rest of Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 61. Asia Pacific: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 62. Asia Pacific: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 63. Asia Pacific: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 64. Asia Pacific: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 65. Asia Pacific: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 66. China: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 67. China: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 68. China: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 69. China: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 70. China: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 71. Japan: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 72. Japan: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 73. Japan: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 74. Japan: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 75. Japan: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 76. India: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 77. India: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 78. India: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 79. India: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 80. India: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 81. Australia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 82. Australia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 83. Australia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 84. Australia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 85. Australia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 86. South Korea: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 87. South Korea: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 88. South Korea: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 89. South Korea: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 90. South Korea: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 91. Rest of APAC: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 92. Rest of APAC: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 93. Rest of APAC: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 94. Rest of APAC: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 95. Rest of APAC: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 96. Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 97. Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 98. Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 99. Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 100. Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 101. South Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 102. South Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 103. South Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 104. South Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 105. South Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 106. Saudi Arabia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 107. Saudi Arabia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 108. Saudi Arabia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 109. Saudi Arabia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 110. Saudi Arabia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 111. United Arab Emirates: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 112. United Arab Emirates: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 113. United Arab Emirates: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 114. United Arab Emirates: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 115. United Arab Emirates: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 116. Rest of Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 117. Rest of Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 118. Rest of Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 119. Rest of Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 120. Rest of Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 121. South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 122. South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 123. South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 124. South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 125. South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 126. Brazil: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 127. Brazil: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 128. Brazil: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 129. Brazil: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 130. Brazil: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 131. Argentina: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 132. Argentina: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 133. Argentina: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 134. Argentina: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 135. Argentina: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 136. Rest of South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 137. Rest of South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 138. Rest of South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 139. Rest of South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 140. Rest of South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 141. Recent Organic Growth Strategies in Anatomic Pathology Market
Table 142. Recent Inorganic Growth Strategies in the Anatomic Pathology Market
Table 143. Glossary of Terms, Anatomic Pathology Market
List of Figures
Figure 1. Anatomic Pathology Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Anatomic Pathology Market Revenue (US$ Million), 2021–2031
Figure 5. Anatomic Pathology Market Share (%) – by Product and Services (2023 and 2031)
Figure 6. Services: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Instruments: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Consumables: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Anatomic Pathology Market Share (%) – by Application (2023 and 2031)
Figure 10. Disease Diagnosis: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Drug Discovery and Development: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Others: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Anatomic Pathology Market Share (%) – by End User (2023 and 2031)
Figure 14. Hospitals: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. Research Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Diagnostic Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Others: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Anatomic Pathology Market Breakdown by Region, 2023 and 2031 (%)
Figure 19. North America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 20. North America: Anatomic Pathology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 21. United States: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 22. Canada: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 23. Mexico: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 24. Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 25. Europe: Anatomic Pathology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 26. United Kingdom: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 27. Germany: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 28. France: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 29. Italy: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 30. Spain: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 31. Rest of Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 32. Asia Pacific: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 33. Asia Pacific: Anatomic Pathology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 34. China: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 35. Japan: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 36. India: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 37. Australia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 38. South Korea: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 39. Rest of APAC: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 40. Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 41. Middle East and Africa: Anatomic Pathology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 42. South Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 43. Saudi Arabia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 44. United Arab Emirates: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 45. Rest of Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 46. South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 47. South and Central America: Anatomic Pathology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 48. Brazil: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 49. Argentina: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 50. Rest of South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 51. Growth Strategies in Anatomic Pathology Market
The List of Companies - Anatomic Pathology Market
- F. Hoffmann-La Roche Ltd
- Beckman Coulter Inc
- Hologic Inc
- Agilent Technologies Inc
- BioGenex Laboratories Inc
- Diapath S.p.A.
- Bio SB
- Merck KGaA
- BD
- PHC Holdings Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For